Search

Your search keyword '"Peter, Passmore"' showing total 327 results

Search Constraints

Start Over You searched for: Author "Peter, Passmore" Remove constraint Author: "Peter, Passmore"
327 results on '"Peter, Passmore"'

Search Results

1. Developing a person-centered stated preference survey for dementia with Lewy bodies: value of a personal and public involvement process

2. Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential

3. Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection

4. Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?

5. Improving medicines management for people with dementia in primary care: a qualitative study of healthcare professionals to develop a theory-informed intervention

6. Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT

7. Souvenaid in the management of mild cognitive impairment: an expert consensus opinion

8. Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

9. Feasibility of Repeated Assessment of Cognitive Function in Older Adults Using a Wireless, Mobile, Dry-EEG Headset and Tablet-Based Games

10. Factors influencing transition to care homes for people with dementia in Northern Ireland

11. Evaluation of the impact of telementoring using ECHO© technology on healthcare professionals’ knowledge and self-efficacy in assessing and managing pain for people with advanced dementia nearing the end of life

12. Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism

13. A feasibility study of a theory-based intervention to improve appropriate polypharmacy for older people in primary care

14. Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.

15. New insights into the genetic etiology of Alzheimer's disease and related dementias

16. Development of an intervention to improve appropriate polypharmacy in older people in primary care using a theory-based method

17. A qualitative study to inform adaptations to a brain health intervention for older adults with type 2 diabetes living in rural regions of Ireland

18. Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

19. Retinal microvascular network attenuation in Alzheimer's disease

20. Plasma Markers of Neurodegeneration Associated with Postoperative Delirium in an Older Elective Arthroplasty Population

21. Cerebrospinal Fluid Markers of Neurodegeneration Associated with Postoperative Delirium in an Older Elective Arthroplasty Population

22. Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations

23. Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations.

24. Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial.

25. Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)

26. Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection

27. Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

28. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia

29. Anticholinergic drug use and risk of mortality for people with dementia in Northern Ireland

30. Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer’s Disease (AD) Pathology Than in Severe AD Pathology

31. Evaluation of liraglutide in the treatment of Alzheimer's disease

32. Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential

33. Signed Distance Correlation (SiDCo): A network analysis application of distance correlation for identifying metabolic networks disrupted in Dementia with Lewy Bodies

34. Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism

35. Analysis of alteration of p75NTR processing and signalling by PS2 mutation and γ-secretase inhibition

36. Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease.

37. Serum xanthophyll carotenoids are associated with estimated glomerular filtration rate in an aged cohort

38. Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease

39. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.

40. Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia

41. Factors influencing transition to care homes for people with dementia in Northern Ireland

42. Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?

43. Long-Term Care for Patients with Dementia

44. The influence of antipsychotics and antidepressants on people with dementia in Northern Ireland: A retrospective analysis

45. Assessing the relationship between cognitive dysfunction and brain atrophy in Alzheimer's disease

46. Relationship between spectral analysis, SUV and SUV Pons ratio as a measure of cerebral glucose metabolic rate in Alzheimer's disease

47. Adherence to a Mediterranean diet is associated with better cognitive performance many years later in the PRIME cohort

48. Influence of cerebral glucose metabolic rate on cognitive function in Alzheimer's subjects

49. Variation in retinal microvascular parameters is associated with mild cognitive impairment and Alzheimer’s disease

50. Evaluation of adaption skills in older adults using behavioural and EEG repeated measurements during a visual oddball object detection task

Catalog

Books, media, physical & digital resources